New York, Global Insight Services have recently published a report on Restless Legs Syndrome – Drug Pipeline Landscape, 2022. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Restless Legs Syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move one’s legs. The exact cause of RLS is unknown, but it is thought to be associated with a dysfunction in the brain’s dopamine system. This system is responsible for regulating movement and is also involved in the feeling of pleasure and reward. RLS is thought to be caused by a combination of genetic and environmental factors. Other conditions that contribute to RLS include low levels of iron (iron deficiency), uremia, hypothyroidism, depression, fibromyalgia and Parkinson’s disease.
Symptoms of RLS include leg (or arm) discomfort, urge to move legs, sleep disruption, bedtime behavior problems and daytime sleepiness.
Healthcare provider may conduct a physical and a neurological exam. Other tests like blood tests may be recommended.
Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31017
Report Highlights
Global Insight Service’s, Restless Legs Syndrome – Drug Pipeline Landscape, 2022 report provides an overview of the Restless Legs Syndrome pipeline drugs. This report covers detailed insights on Restless Legs Syndrome drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Restless Legs Syndrome pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Some of the key players involved in development of Restless Legs Syndrome therapeutics are :
Key Players
- Axim Biotechnologies Inc
- Bioprojet SCR
- Luye Pharma Group
- Omeros Corp
Buy this report: https://www.globalinsightservices.com/checkout/single_user/GIS31017
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700